drugset / Trial / NCT04238091
Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to examine fecal transfer as a potential treatment for Alopecia Areata (AA). This trial will attempt to discover if fecal transfer can treat immune-related hair loss.
Timeline
- Start
- 2019-12-19
- Primary completion
- 2022-03-02
- Completion
- 2022-03-02
Outcome
Outcome not reported
Stopped: “Investigator is no longer interested in moving forward with this study”
Publications
- Background Xie WR, Yang XY, Xia HH, Wu LH, He XX. Hair regrowth following fecal microbiota transplantation in an elderly patient with alopecia areata: A case report and review of the literature. World J Clin Cases. 2019 Oct 6;7(19):3074-3081. doi: 10.12998/wjcc.v7.i19.3074.
- Background Rebello D, Wang E, Yen E, Lio PA, Kelly CR. Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant. ACG Case Rep J. 2017 Sep 13;4:e107. doi: 10.14309/crj.2017.107. eCollection 2017.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fecal material transfer therapy | Unknown | 250 ml | Rectal |
| Comparator | Bisacodyl | Small molecule | 20 mg | — |
| Comparator | Ciprofloxacin | Small molecule | 500 mg | — |
| Comparator | GoLyteley | Unknown | 4000 ml | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Comparator | Vancomycin | Other / unclassified | 250 mg | Oral |